
Discover Âé¶¹¹ú²úAV
Âé¶¹¹ú²úAV Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia

Discover Âé¶¹¹ú²úAV
Âé¶¹¹ú²úAV Named to TIME’s World’s Most Sustainable Companies 2025 List

Discover Âé¶¹¹ú²úAV
Same Company, Different Operating System: Carlos’ Neurodiverse Journey

Discover Âé¶¹¹ú²úAV